Fabián Blanco-Fernández

Left Atrial Appendage Occlusion Compared to Anticoagulation in Patients Suffering from Atrial Fibrillation with Advanced Chronic Kidney Disease

Sergio López‐Tejero, Pablo Antúnez‐Muiños, Pilar Fraile Gómez, Fabián Blanco-Fernández et autres

Background/Objectives: Chronic kidney disease (CKD) is a significant risk factor for thrombogenic and bleeding events in patients with atrial fibrillation (AF). Left atrial appendage occlusion (LAAO) is increasingly utilized as an alternative to oral anticoagulation. We aimed to compare LAAO against medical …

es (code pays fourni par la source)

Initial Experience of Orthotopic Tricuspid Valve Replacement in Spain: TRI‐SPA Replace Registry

Julio Echarte‐Morales, Manuel Barreiro‐Pérez, Luis Nombela‐Franco, Xavier Freixa et autres

BACKGROUND: Transcatheter tricuspid valve replacement (TTVR) is a novel technique for the treatment of symptomatic tricuspid regurgitation (TR). AIMS: This study aims to present the initial experience in Spain and report short-term outcomes of this therapy. METHODS: This was a multicenter, retrospective …

es (code pays fourni par la source)

A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study

Pablo Antúnez‐Muiños, Sergio López‐Tejero, Pedro Cepas‐Guillén, Matías Mon-Noboa et autres

BACKGROUND: Antithrombotic treatment (ATT) post-left atrial appendage occlusion (LAAO) remains controversial. Furthermore, most of the patients undergoing LAAO are at a very high bleeding risk. AIMS: This study aimed to compare a simplified versus conventional ATT after LAAO in very high bleeding …

es (code pays fourni par la source)

Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up

Sergio López‐Tejero, Pablo Antúnez‐Muiños, Pilar Fraile Gómez, Gilles Barreira-de Sousa et autres

Abstract Introduction and Objectives Advanced chronic kidney disease (A‐CKD) combined with atrial fibrillation increases the risk of both thrombogenic and bleeding events. Left atrial appendage occlusion (LAAO) may be an alternative to oral anticoagulation to prevent thromboembolic events. We aimed to evaluate …

es (code pays fourni par la source)

Effectiveness and Safety of an Outpatient Program for Percutaneous Left Atrial Appendage Occlusion

Fabián Blanco-Fernández, Pablo Antúnez‐Muiños, Jean C. Núñez, Sergio López‐Tejero et autres

Background: Left atrial appendage occlusion (LAAO) is a safe and effective alternative to oral anticoagulation for thromboprophylaxis in patients with nonvalvular atrial fibrillation. Technological development in devices and imaging techniques, as well as accumulated experience, have increased procedural success rates and decreased …

es, ie (code pays fourni par la source)

Clinical and economic outcomes of a systematic same-day discharge programme after pulmonary vein isolation: comparison between cryoballoon vs. radiofrequency ablation

Javier Jiménez‐Candil, Jesús María Hernández‐Rivas, Alba Cruz Galbán, Fabián Blanco-Fernández et autres

AIMS: Same-day discharge (SDD) is feasible after pulmonary vein isolation (PVI). We aim to compare prospectively cryoballoon (CRYO) vs. radiofrequency (RF) ablation in a systematic SDD programme. METHODS AND RESULTS: We prospectively analysed the 617 scheduled PVI performed consecutively at our institution …

es (code pays fourni par la source)

Left Atrial Appendage Occlusion Under Miniaturized Transesophageal Echocardiographic Guidance and Conscious Sedation

Adel Aminian, Nina Leduc, Xavier Freixa, Martin John Swaans et autres

be, es, nl (code pays fourni par la source)

Circulating Leves Of Mir-140 As Biomarker Of Decreased Risk Of Incidence Knee Osteoarthritis: Data From The Osteoarthritis Initiative

M. Blanco-Blanco, I. Rego-Pérez, Vanesa Balboa Barreiro, C. Núñez-Carro et autres

es (code pays fourni par la source)